Resumen de las recomendaciones del NICE | 29 ABR 13

Reconocimiento y tratamiento de la psicosis y la esquizofrenia en niños y adolescentes

Las recomendaciones intentan mejorar la provisión y el acceso a intervenciones psicológicas, en especial la intervención familiar y la terapia conductual cognitiva, así como también el acceso a la educación y el trabajo.
13
Autor/a: Dres. Kendall T, Hollis C, Stafford M, Taylor C BMJ2013;346:f150
INDICE:  1. Artículo | 2. Referencias
Referencias

1 Burd L, Kerbeshian J. A North Dakota prevalence study of schizophrenia presenting in childhood. J Am Acad Child Adolesc Psychiatry 1987; 26:347-50.
2 Gillberg C. Epidemiology of early onset schizophrenia. In: RemschmidtH, ed Schizophrenia in children and adolescents. Cambridge University Press, 2001: 43-59.
3 Thomsen PH. Schizophrenia with childhood and adolescent onset—a nationwide register-based study. Acta Psychiatr Scand 1996; 94:187-93.
4 World Health Organization. Division of Epidemiological Surveillance, Health Situation, and Trend Assessment. Global estimates for health situation assessment and projections 1990. World Health Organization, 1990.
5 Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010; 196: 116-21.
6 Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the Prospective European Prediction of Psychosis Study. Arch Gen Psychiatry 2010; 67:241-51.
7 NHS Confederation. Early intervention in psychosis services. Briefing 2011(219). www.iris-initiative.org.uk/silo/files/nhs-confederation-briefing-on-early-intervention-in-psychosis.pdf.
8 National Institute for Health and Clinical Excellence. Psychosis and schizophrenia in children and young people: recognition and management.(Clinical guideline155.)2013. http://guidance.nice.org.uk/CG155.
9 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition.(DSM-IV). American Psychiatric Association, 1994.
10 World Health Organization.The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization, 1992.
11 National Institute for Health and Clinical Excellence. Post-traumatic stress disorder (PTSD): the management of PTSD in adults and children in primary and secondary care.(Clinical guideline 26.) 2005. http://guidance.nice.org.uk/CG26.
12 National Institute for Health and Clinical Excellence. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder (Clinical guideline 31.) 2005. http://guidance.nice.org.uk/CG31.
13 National Institute for Health and Clinical Excellence. Depression in children and young people: identification and management in primary, community and secondary care.(Clinical guideline28.) 2005.http://guidance.nice.org.uk/CG28.
14 National Institute for Health and Clinical Excellence. Borderline personality disorder: treatment and management.(Clinical guideline 78) 2009.http://guidance.nice.org.uk/CG78.
15 National Institute for Health and Clinical Excellence. Antisocial personality disorder: treatment, management and prevention.(Clinical guideline 77) 2009.http://guidance. nice.org.uk/CG77.
16 National Institute for Health and Clinical Excellence. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence.(Clinical guideline 115) 2011.http://guidance.nice.org.uk/CG115.
17 National Institute for Health and Clinical Excellence. Alcohol-use disorders: preventing the development of hazardous and harmful drinking.(Public health guidance 24.) 2010. http://guidance.nice.org.uk/PH24.
18 National Institute for Health and Clinical Excellence. Alcohol-use disorders: diagnosis and clinical management of alcohol-related physical complications.(Clinical guideline100.) 2010.http://guidance.nice.org.uk/CG100.
19 National Institute for Health and Clinical Excellence. Drug misuse: psychosocial interventions. (Clinical guideline 51.) 2007.http://guidance.nice.org.uk/CG51.
20 National Institute for Health and Clinical Excellence. Drug misuse: opioid detoxification. (Clinical guideline 52.)2009.http://guidance.nice.org.uk/CG52.
21 National Institute for Health and Clinical Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. (Clinical guideline 82.) 2009.http://guidance.nice.org.uk/CG82.
22 Pinfold V, Smith J, Shiers D. Audit of early intervention in psychosis service development in England 2005. Psychiatric Bulletin 2007; 31:7-10.
23 Borneo A. Your choice: results from the your treatment, your choice survey 2008—final report. 2008. www.rethink.org/how_we_can_help/our_campaigns/nice_esquizofrenia_g.html.
24 Prescribing Observatory for Mental Health.Topic 10b Re-audit report: prescribing antipsychotics for children and adolescents. CCGI119 (data on file). London: Royal College of Psychiatrists, 2012.
25 De Hert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry 2011 ;26:144-58.
 

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2021